Exicure, Inc. (XCUR)
1.05
-0.08
(-7.08%)
USD |
NASDAQ |
Oct 23, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
Exicure Enterprise Value : 4.976M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.976M |
| October 22, 2026 | 5.486M |
| October 21, 2026 | 4.721M |
| October 20, 2026 | 4.649M |
| October 19, 2026 | 4.848M |
| October 16, 2026 | 5.422M |
| October 15, 2026 | 5.422M |
| October 14, 2026 | 5.995M |
| October 13, 2026 | 5.613M |
| October 12, 2026 | 5.231M |
| October 09, 2026 | 4.976M |
| October 08, 2026 | 4.657M |
| October 07, 2026 | 4.784M |
| October 06, 2026 | 5.167M |
| October 05, 2026 | 5.103M |
| October 02, 2026 | 5.613M |
| October 01, 2026 | 5.804M |
| September 30, 2026 | 5.867M |
| September 29, 2026 | 5.549M |
| September 28, 2026 | 6.155M |
| September 25, 2026 | 6.059M |
| September 24, 2026 | 6.123M |
| September 23, 2026 | 6.187M |
| September 22, 2026 | 6.505M |
| September 21, 2026 | 6.314M |
| Date | Value |
|---|---|
| September 18, 2026 | 6.123M |
| September 17, 2026 | 6.888M |
| September 16, 2026 | 6.760M |
| September 15, 2026 | 6.633M |
| September 14, 2026 | 7.015M |
| September 11, 2026 | 7.206M |
| September 10, 2026 | 7.015M |
| September 09, 2026 | 7.398M |
| September 08, 2026 | 7.270M |
| September 04, 2026 | 6.250M |
| September 03, 2026 | 6.123M |
| September 02, 2026 | 6.505M |
| September 01, 2026 | 6.569M |
| August 31, 2026 | 6.633M |
| August 28, 2026 | 6.505M |
| August 27, 2026 | 7.270M |
| August 26, 2026 | 6.314M |
| August 25, 2026 | 5.868M |
| August 24, 2026 | 5.613M |
| August 21, 2026 | 5.613M |
| August 20, 2026 | 6.569M |
| August 19, 2026 | 7.525M |
| August 18, 2026 | 7.398M |
| August 17, 2026 | 7.079M |
| August 14, 2026 | 6.250M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -63.02M |
| Century Therapeutics, Inc. | 182.55M |
| Absci Corp. | 1.378B |
| Celularity, Inc. | 97.88M |
| Cardio Diagnostics Holdings, Inc. | -0.2154M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.121M |
| Total Expenses (Quarterly) | 1.121M |
| EPS Diluted (Quarterly) | -0.1759 |
| Earnings Yield | -124.1% |
| Normalized Earnings Yield | -110.02 |